1,092 results on '"Cattan A"'
Search Results
2. The gendered division of paid and domestic work under lockdown
3. The Long-Term Effects of Student Absence: Evidence from Sweden
4. Co-infection patterns of vector-borne zoonotic pathogens in owned free-ranging dogs in central Chile
5. Les enjeux de la cardiologie de demain : le livre blanc du CNP cardiovasculaire
6. Quelques sources pour écrire une histoire politique de l’élevage du cheval en France en 1789
7. Early Childhood Development, Human Capital, and Poverty
8. High Trypanosoma cruzi prevalence in armadillo (Zaedyus pichiy; Xenarthra: Chlamyphoridae) populations from Mendoza, Argentina
9. First generation elite the role of school networks
10. Assessment of the reliability of MSI status and dMMR proteins deficiency screening on endoscopic biopsy material in esophagus and gastric adenocarcinoma
11. Attendez, attendez … j’ai une question. Hommage à Thérèse Saint-Julien (1941-2021)
12. Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition
13. Predictive factors for the success of endoscopic dilation of esophageal caustic stricture: the experience of a French tertiary reference center
14. Trypanosoma cruzi Survey in Poached Pichis (Zaedyus pichiy; Mammalia, Cingulata) from Mendoza, Argentina
15. Supplementary Data from Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages
16. Supplementary Figure Legends from Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages
17. Data from Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages
18. Supplementary Table 2 from Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages
19. Supplementary Figure S6 from The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy
20. Supplementary Table S1 from S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab
21. Data from S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab
22. Supplementary Figure S5 from The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy
23. Supplementary Figure S1 from The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy
24. Supplementary Figure S3 from The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy
25. Supplementary Figure S1 from S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab
26. Supplementary Table S1 from The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy
27. Supplementary information from The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy
28. Supplementary Figure Legends from S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab
29. Supplementary Figure S4 from The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy
30. Supplementary Figure S2 from S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab
31. Supplementary Table from Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
32. Supplementary Data from Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
33. Supplementary Figure from Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
34. Data from Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
35. pyRiemann-qiskit: A Sandbox for Quantum Classification Experiments with Riemannian Geometry
36. Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer-Term Follow-Up From the Phase 3 KEYNOTE-240 Trial
37. How does the association between special education need and absence vary overtime and across special education need types?
38. Infrastructure for Rapid Open Knowledge Network Development
39. Isolation and characterization of a novel Lambda‐like phage infecting the bloom‐forming cyanobacteria Cylindrospermopsis raciborskii
40. Introduction to the special section: When migrants produce the city: Everyday negotiations of urban space / Introduction de la section spéciale : Quand les migrants produisent la ville : Négociations quotidiennes de l'espace urbain
41. Women as Agents of Change: Male Circumcision and HIV Prevention in Kenya
42. Perioperative Oral Pregabalin Results in Postoperative Pain Scores Equivalent to Those of Interscalene Brachial Plexus Block After Arthroscopic Rotator Cuff Repair: A Randomized Clinical Trial
43. Molecular surveillance of potential SARS-CoV-2 reservoir hosts in wildlife rehabilitation centers
44. Evaluating and Improving the Coreference Capabilities of Machine Translation Models
45. Le Digital Markets Act permettra-t-il à l’Europe de reprendre le pouvoir sur les GAFA ? Probablement pas tout de suite
46. The impact of area level mental health interventions on outcomes for secondary school pupils: Evidence from the HeadStart programme in England
47. The health effects of universal early childhood interventions: evidence from Sure Start
48. UN Measures for Redress
49. International Legal Status of Jerusalem
50. Jerusalem between 1948 and 1967
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.